MARKET

KRRO

KRRO

Korro Bio, Inc.
NASDAQ
12.91
-0.35
-2.64%
After Hours: 12.91 0 0.00% 19:30 08/28 EDT
OPEN
13.13
PREV CLOSE
13.26
HIGH
13.55
LOW
12.80
VOLUME
67.37K
TURNOVER
--
52 WEEK HIGH
55.89
52 WEEK LOW
5.20
MARKET CAP
190.11M
P/E (TTM)
-1.2905
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KRRO last week (0817-0821)?
Weekly Report · 5d ago
Korro Bio Moves KRRO-121 Into First Human Trials, Raising the Stakes in Rare Disease RNA Editing
TipRanks · 08/20 16:31
Korro Bio Price Target Maintained With a $15.00/Share by HC Wainwright & Co.
Dow Jones · 08/20 11:49
HC Wainwright & Co. Reiterates Buy on Korro Bio, Maintains $15 Price Target
Benzinga · 08/20 11:39
Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), CervoMed (CRVO) and Korro Bio (KRRO)
TipRanks · 08/20 10:30
Korro Bio Advances KRRO-121 Into First Human Trial
TipRanks · 08/19 20:31
Korro Bio Submits To Australian Alfred Health Human Ethics Committee To Start Phase 1/2 Clinical Study Of KRRO-121 To Treat Hyperammonemia In Patients With Urea Cycle Disorders
Benzinga · 08/19 20:11
Weekly Report: what happened at KRRO last week (0810-0814)?
Weekly Report · 08/17 09:33
More
About KRRO
Korro Bio, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops, and commercializes genetic medicines based on editing ribonucleic acid (RNA), enabling treatment of both rare and highly prevalent diseases. The Company is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, it is expanding the reach of genetic medicines. Using its oligonucleotide-based approach, the Company brings its medicines to patients by leveraging its proprietary platform. The Company’s first development candidate, KRRO-110, is in development as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD) that has the potential to be disease-modifying and provide a differentiated therapeutic option.

Webull offers Korro Bio Inc stock information, including NASDAQ: KRRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KRRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KRRO stock methods without spending real money on the virtual paper trading platform.